The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback